BIOGEN INC. is 20.0x more valuable than Immunocore Holdings plc by market capitalization ($29.53 B vs $1.47 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMCR | BIIB |
|---|---|---|
| Market cap | $1.47 B | $29.53 B |
| US-listed rank | #2357 | #476 |
| Revenue (latest FY) | $400.02M | $9.89B |
| Net income (latest FY) | -$35.51M | $1.29B |
| Net margin | -8.9% | 13.1% |
| P/E (trailing FY) | - | 22.8 |
| SEC filings | 265 | 2,690 |
BIOGEN INC. is 20.0x more valuable than Immunocore Holdings plc by market capitalization ($29.53 B vs $1.47 B).
In their latest fiscal years, Immunocore Holdings plc reported $400.02M in revenue while BIOGEN INC. reported $9.89B.
Full pages: Immunocore Holdings plc and BIOGEN INC., or browse the full rankings.